Pharmaceutical companies are often seen to be quite conservative when it comes to embracing digital marketing. This holds especially true in Australia where marketers need to comply with a range of strict guidelines regulating the marketing and advertising of prescription-only as well as over-the-counter medications.

Keira Parry is the Digital Acceleration Manager for Bayer Consumer Healthcare. Taking the regulatory hurdles into account, her role is to identify digital opportunities and to ensure that Bayer takes full advantage of those opportunities moving forward. In this episode, Keira explains how she facilitates the digital transformation process in a highly regulated environment, making sure that digital is an enabler for achieving brand and organisation objectives.

We will learn how Bayer’s digital transformation is widely supported across the organisation and what key digital decisions are driven by.